Familial Melanoma: Diagnostic and Management Implications

Area of Science:

• Genetics
• Dermatology
• Oncology

Background:

• 5%-10% of cutaneous melanoma cases have a familial occurrence.
• This review focuses on melanoma susceptibility genes, genetic testing, and management strategies for familial cases.

Purpose of the Study:

• To review known melanoma susceptibility genes.
• To discuss genetic testing protocols for familial melanoma.
• To outline management implications for individuals with hereditary melanoma risk.

Main Methods:

• Literature review of genetic predisposition in melanoma.
• Analysis of current genetic testing recommendations and their limitations.
• Discussion of clinical management strategies for melanoma families.

Main Results:

• CDKN2A mutations are found in 20%-40% of melanoma families, associated with increased risk and other cancers.
• Other rare mutations (CDK4, BAP1, TERT, POT1, ACD, TERF2IP, MITF) explain an additional 10% of familial clustering.
• Genetic susceptibility remains unexplained in 50% of melanoma families; multigene panel testing is under debate.
• Genetic testing is currently advised only for CDKN2A and CDK4.
• Genetic counseling is crucial for informing families about risks, testing, and management.

Conclusions:

• Genetic testing for high-penetrance melanoma genes is recommended for selected individuals in melanoma families after thorough counseling.
• All members of melanoma families should adopt sun-safe behaviors, perform self-examinations, and undergo regular medical surveillance.